Web Results



Zanamivir INN /zəˈnæmᵻvɪər/ is a neuraminidase inhibitor used in the treatment and prophylaxis of influenza caused by influenza A and B viruses.

Relenza (Zanamivir) Drug Information: Description, User Reviews ...


Learn about the prescription medication Relenza (Zanamivir), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.

Zanamivir Oral Inhalation: MedlinePlus Drug Information


Jul 1, 2010 ... Zanamivir is used in adults and children at least 7 years of age to treat some types of influenza ('flu') in people who have had symptoms of the ...

Zanamivir: Indications, Side Effects, Warnings - Drugs.com


Easy to read patient leaflet for zanamivir. Includes indications, proper use, special instructions, precautions, and possible side effects.

CDC Considerations Related to Investigational Use of Intravenous ...


Feb 22, 2016 ... This page provides guidance specific to the use of investigational use of intravenous zanamivir, but not for the use of FDA-approved ...

Influenza Textbook | Zanamivir - Influenza Report


Zanamivir is an orally inhaled powder currently approved in 19 countries for the treatment of, and in two for the prophylaxis of influenza A and B. Zanamivir is a ...

Relenza [zanamivir for inhalation] - GSK Source


RELENZA (zanamivir) Inhalation Powder, for oral inhalation. Initial U.S. Approval: .... (zanamivir) Inhalation Powder is indicated for treatment of uncomplicated.

Relenza (zanamivir) - NetDoctor


Dec 17, 2013 ... Relenza inhalation powder contains the active ingredient zanamivir, which is a type of medicine called a neuraminidase inhibitor. It is used to ...

Relenza (zanamivir) dosing, indications, interactions, adverse ...


Medscape - Indication-specific dosing for Relenza (zanamivir), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy ...

(zanamivir) Information - U.S. Food and Drug Administration


Dec 16, 2015 ... Relenza (zanamivir) is approved for treatment of acute uncomplicated illness due to influenza A and B in patients 7 years of age and older.

Zanamivir Highlights
ZANAMIVIR (za NA mi veer) is an antiviral medicine. It is used to prevent and treat flu infections caused by influenza A or B virus. It will not work for colds, other types of flu, or other viral infections. More »
Source: healthline.com
More Info

zanamivir, Relenza: Drug Facts, Side Effects and Dosage


Jan 6, 2015 ... Learn about zanamivir (Relenza) a drug prescribed for the treatment of flu viruses A and B (including H1N1 or swine flu). Side effects, drug ...

DrugBank: Zanamivir


Name, Zanamivir. Accession Number, DB00558 (APRD00378). Type, Small Molecule. Groups, Approved, Investigational. Description. A guanido-neuraminic  ...

Zanamivir medical facts from Drugs.com


Physician reviewed zanamivir patient information - includes zanamivir description, dosage and directions.